Skip to main content

Intraportal Delivery of Immunosuppressants to Intrahepatic Islet Allografts

  • Chapter
Local Immunosuppression of Organ Transplants

Part of the book series: Medical Intelligence Unit ((MIU.LANDES))

  • 53 Accesses

Abstract

For many years, the prevailing schema of alloreactivity made local immunosuppression illogical.1 The understanding was that a vascularized allograft was recognized by the host through peripheral sensitization. Host immune cells circulating through the graft were exposed to nonself histocompatibility antigens. Subsequent proliferation of responder cells occurred in the spleen or lymph nodes. The effector response was mediated by sensitized lymphoid cells returning to the graft and destroying cells bearing foreign histocompatibility antigens. Nonspecific immunosuppressive agents, such as azathioprine and steroids, interfered with proliferating cells in the spleen and other lymphoid depots. Given this schema, the value of immunosuppression at the graft site was doubtful.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ascher NL, Hoffman R, Hanto DW et al. Cellular events within the rejecting allograft. Transplantation 1983; 35: 193.

    Article  PubMed  CAS  Google Scholar 

  2. Hayry P Intragraft events in allograft destruction. Transplantation 1984; 38: 1.

    Article  PubMed  CAS  Google Scholar 

  3. Orosz CG, Bishop DK, Ferguson RM. In vivo mechanisms of alloreactivity. Transplantation 1989; 48: 818.

    Article  PubMed  CAS  Google Scholar 

  4. Stepkowski SM, Goto S, Ito T et al. Prolongation of heterotopic heart allograft survival by local delivery of continuous low-dose cyclosporine therapy. Transplantation 1989; 47: 17.

    Article  PubMed  CAS  Google Scholar 

  5. Ruers TJM, Buurman WA, Smits JFM et al. Local treatment of renal allografts, a promising way to reduce the dosage of immunosuppressive drugs. Transplantation 1986; 41: 156.

    Article  PubMed  CAS  Google Scholar 

  6. Ruers TJM, Daeman MJAP, Thijssen HHW et al. Sensitivity of graft rejection in rats to local immunosuppressive therapy. Transplantation 1988; 46: 820.

    Article  PubMed  CAS  Google Scholar 

  7. Gruber SA, Canafax DM, Cipolle RJ et al. Local immunosuppression of the vascularized graft. Surgery 1990; 107: 209.

    PubMed  CAS  Google Scholar 

  8. Gruber SA. The case for local immunosuppression. Transplantation 1992; 54: 1.

    Article  PubMed  CAS  Google Scholar 

  9. Wang X, Berezniak R, Tafra L et al. Intraportal FK506 improves intrahepatic islet allograft survival. Transplant Proc 1991; 23: 3211.

    PubMed  CAS  Google Scholar 

  10. Wang X, Alfrey EJ, Posselt A et al. Intraportal delivery of immunosuppression to intrahepatic islet allograft recipients. Transplant Int 1995; 8: 268.

    Article  CAS  Google Scholar 

  11. Reckard CR, Barker CF. Transplantation of isolated pancreatic islets across strong and weak histocompatibility barriers. Transplant Proc 1973; 5: 761.

    PubMed  CAS  Google Scholar 

  12. Naji A, Silvers WK, Plotkin SA et al. Successful islet transplantation in spontaneous diabetes. Surgery 1979; 86: 218.

    PubMed  CAS  Google Scholar 

  13. Groth CG, ed. Pancreas and Islet Transplantation. Diabetes 1989; 38(suppl):1.

    Google Scholar 

  14. Theeuwes F, Yum SI. Principles of design and operation of generic osmotic pumps for the delivery of semisolid and liquid drug formulations. Ann Biomed Eng 1976; 4: 343.

    Article  PubMed  CAS  Google Scholar 

  15. Andersson A, Korsgren O, Jansson L. Intraportally transplanted pancreatic islets revascularized from hepatic arterial system. Diabetes 1989; 38 (suppl): 192.

    Article  PubMed  Google Scholar 

  16. Nash JR, Bell PRF. Islet transplantation - synergism between antilymphocyte and antimacrophage agents. J Surg Res 1984; 36: 154.

    Article  PubMed  CAS  Google Scholar 

  17. Gray DWR, Morris PJ. Developments in isolated pancreatic islet transplantation. Transplantation 1987; 43: 321.

    Article  PubMed  CAS  Google Scholar 

  18. Qian J, Kokudo S, Sato S et al. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. Transplantation 1987; 43: 538.

    Article  PubMed  CAS  Google Scholar 

  19. Mattingly JA, Waksman BH. Immunologic suppression after oral administration of antigen. J Immunol 1978; 121: 1878.

    PubMed  CAS  Google Scholar 

  20. Dubernard JM, Sutherland DER. International Handbook of Pancreas Transplantation. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1989.

    Book  Google Scholar 

  21. Van Der Vliet JA, Kaufman DB, Meloche RM et al. A simple method of canine pancreatic islet isolation and intrahepatic transplantation. J Surg Res 1989; 46: 126.

    Google Scholar 

  22. Alejandro R, Cutfield R, Shienvold FL et al. Successful long-term survival of pancreatic islet allografts in spontaneous or pancreatectomy-induced diabetes in dogs. Diabetes 1985; 34: 825.

    Article  PubMed  CAS  Google Scholar 

  23. Kamei T, Yasunami Y. Demonstration of donor specific unresponsiveness in rat islet allografts: importance of transplant site for induction by cyclosporin A and maintenance. Diabetologia 1989; 32: 779.

    Article  PubMed  CAS  Google Scholar 

  24. Reece-Smith H, Dutoit DF, McShane P et al. Prolonged survival of pancreatic islet allografts transplanted beneath the renal capsule. Transplantation 1981; 31: 305.

    Article  PubMed  CAS  Google Scholar 

  25. Ziegler MM, Reckard CR, Barker CF. Long term metabolic and immunological considerations in transplantation of pancreatic islets. J Surg Res 1974; 16: 575.

    Article  PubMed  CAS  Google Scholar 

  26. Edsbacker S, Andersson P, Lindberg C et al. Metabolic acetal splitting of budesonide. Drug Metab Disp 1987; 15: 403.

    CAS  Google Scholar 

  27. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725.

    Article  PubMed  CAS  Google Scholar 

  28. Hahn HJ, Laube F, Lucke S et al. Toxic effects of cyclosporine on the endocrine pancreas of wistar rats. Transplantation 1986; 41: 44.

    Article  PubMed  CAS  Google Scholar 

  29. Peters DH, Fitton A, Plosker GL et al. Tacrolimus. Drugs 1993; 46: 746.

    Article  CAS  Google Scholar 

  30. Jain AB, Ventakaramanan R, Cadoff E et al. Effect of hepatic dysfunction and T-tube clamping on FK506 pharmacokinetics and trough concentrations. Transplant Proc 1990; 22: 57.

    PubMed  CAS  Google Scholar 

  31. Hirano Y, Fujihira S, Ohara K et al. Morphological and functional changes of islets of langerhans in FK506-treated rats. Transplantation 1992; 53: 889.

    Article  PubMed  CAS  Google Scholar 

  32. Ohara K, Billington R, James RW et al. Toxicologic evaluation of FK506. Transplant Proc 1990: 22: 83.

    PubMed  CAS  Google Scholar 

  33. Venkataramanan R, Jain A, Cadoff E, at al. Pharmacokinetics of FK506. Transplant Proc 1990; 22: 52.

    PubMed  CAS  Google Scholar 

  34. Tamura K, Kobayashi M, Hoshimoto K. A highly sensitive method to assay FK506 levels in plasma. Transplant Proc 1987; 19: 23.

    PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dafoe, D.C., Alfrey, E.J. (1996). Intraportal Delivery of Immunosuppressants to Intrahepatic Islet Allografts. In: Local Immunosuppression of Organ Transplants. Medical Intelligence Unit. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-22105-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-22105-1_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-22107-5

  • Online ISBN: 978-3-662-22105-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics